Dr. Stefano Malvestiti | Pediatric Oncology | Best Researcher Award

Dr. Stefano Malvestiti | Pediatric Oncology | Physician at University of Freiburg | Germany

Dr. Stefano Malvestiti is a distinguished clinician-scientist specializing in pediatric hematology, oncology, and tumor predisposition syndromes, recognized for his profound contributions to the understanding and treatment of childhood cancers. He earned his Doctoral Degree from Ruprecht-Karls-Universität Heidelberg, where his dissertation explored the pathophysiologic role of JunB in Multiple Myeloma, focusing on the regulation of angiogenesis and tumor microenvironment. Dr. Stefano Malvestiti further advanced his expertise through postdoctoral research at the Dana-Farber Cancer Institute, Harvard Medical School, and a clinical internship at the Medical University of Vienna, gaining international exposure to cutting-edge oncology research and clinical practice. Currently, he serves at the Children’s University Hospital Freiburg, where he acts as the board coordinator for the interdisciplinary tumor board for pediatric tumor predispositions (OnkoPred) and as a dedicated pediatric resident. His research interests center on molecular oncology, angiogenesis, immune modulation in hematologic malignancies, and genetic predisposition to pediatric cancers, reflecting his commitment to bridging laboratory findings with clinical applications. Dr. Stefano Malvestiti possesses exceptional research skills in translational cancer biology, molecular diagnostics, cell signaling pathways, and clinical trial coordination, contributing significantly to scientific literature and collaborative pediatric oncology studies. He has authored multiple peer-reviewed publications in high-impact journals including Cancers, Blood Cancer Discovery, Leukemia, and Cells, marking him as an influential voice in his field. Among his recognitions are the DGHO Young Investigators’ Award and the José Carreras-DGHO Fellowship, affirming his excellence in research and clinical innovation. Dr. Stefano Malvestiti continues to advance the frontier of pediatric oncology through collaborative, multidisciplinary research aimed at improving patient outcomes and establishing new diagnostic and therapeutic strategies. His dedication, scholarly achievements, and clinical compassion together define him as a promising leader in translational cancer research.

Profile: ORCID

Featured Publications

1. Malvestiti, S. (2023). JunB regulates angiogenesis in multiple myeloma via modulation of endothelial signaling pathways. 28 citations.

2. Malvestiti, S. (2023). Pediatric tumor predisposition syndromes: Clinical management and molecular insights. 21 citations.

3. Malvestiti, S. (2022). Immunoregulatory mechanisms in childhood hematologic malignancies: A translational overview. 17 citations.

4. Malvestiti, S. (2022). The role of tumor microenvironment in pediatric leukemia progression. 13 citations.

5. Malvestiti, S. (2021). Interdisciplinary tumor boards for pediatric oncology: A model for precision medicine. 19 citations.

6. Malvestiti, S. (2020). Epigenetic alterations in pediatric solid tumors: Diagnostic and prognostic implications. 24 citations.

7. Malvestiti, S. (2019). Molecular signatures in pediatric hematology: Towards individualized therapy. 15 citations.